[Specific hyposensitization in allergic diseases (author's transl)].
Hyposensitization with semi-depot extracts was effective in 439 of 533 patients (82.4%) with allergic manifestations. The result suggests that treatment will be most effective when (1) the patient is young, (2) the disease is located in the respiratory tract, (3) the disease has been of relatively short duration, (4) the hyposensitization extract contains only one type of allergen, (5) only a few allergens are involved, (6) treatment continues over a long period of time, (7) the final dosage is high, and (8) dosage and time schedules are carefully followed. Success does not depend on the patient's sex or the occurrence of side effects during the treatment.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D007223:Infant; D008297:Male; D008875:Middle Aged; D012130:Respiratory Hypersensitivity / Q000188:drug therapy; D012737:Sex Factors; D011795:Surveys and Questionnaires
Spezifische Hyposensibilisierung bei allergischen Erkrankungen.